A pilot study of L-methionine for the treatment of AIDS-associated myelopathy

Neurology

Volumn 51, Issue 1, 1998, Pages 266-268

  Di Rocco, A ^a,b   Tagliati, M ^a   Danisi, F ^a   Dorfman, D ^a   Moise, J ^a   Simpson, D M ^a  

^a MOUNT SINAI SCHOOL OF MEDICINE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

METHIONINE;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ADULT; ARTICLE; CLINICAL ARTICLE; CLINICAL TRIAL; EVOKED SOMATOSENSORY RESPONSE; FEMALE; HUMAN; MALE; MUSCLE STRENGTH; ORAL DRUG ADMINISTRATION; PRIORITY JOURNAL; SPASTICITY; SPINAL CORD DISEASE; TREATMENT OUTCOME;

EID: 0031815790     PISSN: 00283878     EISSN: None     Source Type: Journal    
DOI: 10.1212/WNL.51.1.266     Document Type: Article

References (10)

1. Petito CK, Navia BA, Cho ES, Jordan BD, George DC, Price RW. Vacuolar myelopathy pathologically resembling subacute combined degeneration in patients with the acquired immunodeficiency syndrome. N Engl J Med 1985;312:874-879.
2. Dal Pan GJ, Glass JD, McArthur JC. Clinicopathologic correlation of HIV-1 associated vacuolar myelopathy: an autopsy based case-control study. Neurology 1994;44:2159-2164.
3. Petito CK, Vecchio D, Chen YT. HIV antigen and DNA in AIDS spinal cords correlate with macrophages infiltration but not with vacuolar myelopathy. J Neuropathol Exp Neurol 19994;53:86-94.
4. Rosenblum M, Scheck AC, Cronin K, et al. Dissociation of AIDS-related vacuolar myelopathy and productive HIV-1 infection of the spinal cord. Neurology 1989;39:892-896.
5. Kieburtz KD, Giang DW, Schiffer RB, Vakil N. Abnormal vitamin B12 metabolism in human immunodeficiency virus infection. Arch Neurol 1991;48:312-314.
6. Scott JM, Dinn JJ, Wilson P, Weir DG. Pathogenesis of sub-acute combined degeneration: a result of methyl group deficiency. Lancet 1981;2:334-337.
7. Scott JM, Molloy AM, Kennedy DG, et al. Effects of destruction of transmethylation in the central nervous system: an animal model. Acta Neurol Scand 1994;(suppl 154):27-31.
8. Surtees R, Hyland K, Smith I. Central nervous system methyl group metabolism in children with neurological complications of HIV infection. Lancet 1990;335:619-621.
9. Keating JN, Trimble KC, Mulcahy F, Scott JM, Weir DG. Evidence of brain methyltransferase inhibition and early brain involvement in HIV-positive patients. Lancet 1991;337: 935-939.
10. Izumo S, Goto I, Itoyama Y, et al. Interferon-alpha is effective in HTLV-1 myelopathy: a multicenter, randomized, double-blinded, controlled trial. Neurology 1996;46:1016-1021.